DGKα-IN-3
DGKα-IN-3 (example 25) is a DGKα inhibitor with the IC50 of 283 nM, extracted from patent WO2021105115. DGKα-IN-2 significantly enhances the anti-tumor effect of anti-PD-1 by increasing the proliferation and function of T cells. DGKα-IN-2 has the potential for cancer and immunology study.
Product Specifications
CAS Number
[2648418-86-2]
UNSPSC
12352005
Target
DGK
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/dgkα-in-3.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(N2CCC3(CC2)CN(CC3)C4=CC=C(C=C4)OC(F)(F)F)C5=C(C=CC=C5)N(C)C1=O)N
Molecular Formula
C26H27F3N4O3
Molecular Weight
500.51
References & Citations
[1]Schmees, Norbert, et al. Preparation of substituted aminoquinolones as DGKα inhibitors for immune activation. WO2021105115.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal HMGB1/HMG-1 Antibody [Alexa Fluor 700]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
Mouse Monoclonal NKG2A/CD159a/KLRC1 Antibody (131411R) [Janelia Fluor 635]
RNF2 (Ring Finger Protein 2, BAP-1, BAP1, DING, HIPI3, Ring1B, Ring2) (MaxLight 750) discontinued
